Table 1. Patient characteristics, INTERMACS level, preoperative lab data, and medications.

Patient ID	1	2	3	4	5	6	7	8	9
Gender	M	M	M	M	M	M	M	M	F
Age	62	66	55	46	64	76	54	71	51
Race	C	C	C	C	C	C	C	C	AA
HF Etiology	I	I	I	NI	I	I	NI	I	NI
BMI	34.2	25.7	30.1	28.1	27.1	23.9	31.3	36.5	22.0
INTERMACS	5	5	6	6	4	5	6	5	5
Diabetes	-	+	-	-	+	-	-	+	-
Device	HW	HW	HMII	HMII	HMII	HMII	HMII	HMII	HMII
BUN (mg/dL)	31	38	31	18	49	27	23	52	30
Creatinine (mg/dL)	1.41	1.56	2.07	1.29	1.81	1.51	0.93	1.58	1.09
NA (mmol/L)	134	139	139	141	126	139	133	143	143
K (mmol/L)	3.4	2.7	4.5	3.8	3.8	4.0	3.1	4.6	3.6
Albumin (g/dL)	3.9	3.5	4.2	3.6	3.9	3.9	4.6	4.6	4.3
Bilirubin (mg/dL)	0.4	1.8	0.6	0.6	0.9	1.5	1.6	0.7	1.2
WBC (109/L)	5.8	7.7	6.2	5.6	4.6	4.3	8.7	11.1	5.8
Beta blocker	+	+	+	+	+	+	+	+	+
ACE/ARB	+		+	+		+	+	+	+
Aldosterone antagonist		+	+	+		+	+		+
Diuretic	+	+	+	+	+	+	+	+	+
Statin		+	+		+	+		+
Aspirin	+	+	+	+	+	+	+	+	+
Amiodarone or Dronederone	+	+
Warfarin		+			+	+	+
LMW Heparin									+
Digoxin	+			+		+	+		+
Plavix		+

M, male; F, female; C, caucasian; AA, African-American; I, ischemic cardiomyopathy; NI, non-ischemic cardiomyopathy; HW, Heartware; HMII, Heartmate II